ATE167872T1 - Peptide aus derivaten der 4-amino-2.2.-difluoro-3-oxo-1.6-hexandisäure als wirkstoffe gegen entzündungen - Google Patents

Peptide aus derivaten der 4-amino-2.2.-difluoro-3-oxo-1.6-hexandisäure als wirkstoffe gegen entzündungen

Info

Publication number
ATE167872T1
ATE167872T1 AT93912277T AT93912277T ATE167872T1 AT E167872 T1 ATE167872 T1 AT E167872T1 AT 93912277 T AT93912277 T AT 93912277T AT 93912277 T AT93912277 T AT 93912277T AT E167872 T1 ATE167872 T1 AT E167872T1
Authority
AT
Austria
Prior art keywords
derivatives
difluoro
oxo
amino
pct
Prior art date
Application number
AT93912277T
Other languages
English (en)
Inventor
Ralph Robinson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE167872T1 publication Critical patent/ATE167872T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT93912277T 1992-07-31 1993-04-21 Peptide aus derivaten der 4-amino-2.2.-difluoro-3-oxo-1.6-hexandisäure als wirkstoffe gegen entzündungen ATE167872T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92288992A 1992-07-31 1992-07-31

Publications (1)

Publication Number Publication Date
ATE167872T1 true ATE167872T1 (de) 1998-07-15

Family

ID=25447720

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93912277T ATE167872T1 (de) 1992-07-31 1993-04-21 Peptide aus derivaten der 4-amino-2.2.-difluoro-3-oxo-1.6-hexandisäure als wirkstoffe gegen entzündungen

Country Status (10)

Country Link
US (1) US5739279A (de)
EP (1) EP0654041B1 (de)
JP (1) JP2602181B2 (de)
AT (1) ATE167872T1 (de)
CA (1) CA2139854A1 (de)
DE (1) DE69319432T2 (de)
DK (1) DK0654041T3 (de)
ES (1) ES2117133T3 (de)
FI (1) FI933424A (de)
WO (1) WO1994003480A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204261B1 (en) 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US5874424A (en) * 1995-12-20 1999-02-23 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
US6008217A (en) * 1995-12-20 1999-12-28 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
US6420522B1 (en) 1995-06-05 2002-07-16 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
US5756466A (en) * 1994-06-17 1998-05-26 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme
US5716929A (en) * 1994-06-17 1998-02-10 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme
EP0820464A2 (de) * 1995-03-31 1998-01-28 Takeda Chemical Industries, Ltd. Cysteinprotease -inhibitor
US5843904A (en) * 1995-12-20 1998-12-01 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1βconverting enzyme
US5968927A (en) * 1996-09-20 1999-10-19 Idun Pharmaceuticals, Inc. Tricyclic compounds for the inhibition of the ICE/ced-3 protease family of enzymes
US6184244B1 (en) * 1996-12-16 2001-02-06 Idun Pharmaceuticals, Inc. C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
EP1062210B1 (de) 1998-03-09 2005-06-01 Vertex Pharmaceuticals Incorporated 1,2-diazepanderivate als inhibitoren des interleukin-1beta umwandelnden enzyms
ES2315010T3 (es) 1998-03-19 2009-03-16 Vertex Pharmaceuticals Incorporated Inhibidores de caspasas.
PE20011350A1 (es) 2000-05-19 2002-01-15 Vertex Pharma PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE)
US20030114362A1 (en) * 2001-06-08 2003-06-19 Novaspin Biotech Gmbh Penta-or tetrapeptide binding to somatostatin receptors and the use of the same
US20030129186A1 (en) 2001-07-25 2003-07-10 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
FR2842810B1 (fr) * 2002-07-25 2006-01-27 Inst Nat Sciences Appliq Nouveaux composes gem difluores, leur procedes de preparation et leurs applications.
GB0411056D0 (en) 2004-05-18 2004-06-23 Novartis Ag Organic compounds
EP1778221A2 (de) 2004-05-27 2007-05-02 Vertex Pharmaceuticals Incorporated Ice-hemmer zur behandlung von autoinflammatorischen erkrankungen
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息系统及其用途
MX2009002893A (es) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
CA2752373C (en) 2009-02-20 2017-10-10 To-Bbb Holding B.V. Glutathione-based drug delivery system
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
US9956260B1 (en) 2011-07-22 2018-05-01 The J. David Gladstone Institutes Treatment of HIV-1 infection and AIDS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL77748A (en) * 1985-02-04 1991-11-21 Merrell Dow Pharma Amino acid and peptide derivatives as peptidase inhibitors
WO1991015577A1 (en) * 1990-04-04 1991-10-17 Black, Roy, A. INTERLEUKIN 1'beta' PROTEASE

Also Published As

Publication number Publication date
DE69319432T2 (de) 1998-10-29
CA2139854A1 (en) 1994-02-17
DE69319432D1 (de) 1998-08-06
US5739279A (en) 1998-04-14
EP0654041A1 (de) 1995-05-24
FI933424A0 (fi) 1993-07-30
ES2117133T3 (es) 1998-08-01
JP2602181B2 (ja) 1997-04-23
JPH07504686A (ja) 1995-05-25
EP0654041B1 (de) 1998-07-01
WO1994003480A1 (en) 1994-02-17
DK0654041T3 (da) 1998-10-26
FI933424A (fi) 1994-02-01

Similar Documents

Publication Publication Date Title
ATE167872T1 (de) Peptide aus derivaten der 4-amino-2.2.-difluoro-3-oxo-1.6-hexandisäure als wirkstoffe gegen entzündungen
FI932229A (fi) Azabicykliska bryggderivat
NZ258368A (en) Substituted amidino compounds, preparation and pharmaceutical compositions thereof
ATE202337T1 (de) Cyclopropylalkansäurederivate
ITMI922699A1 (it) Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
DE69713582D1 (de) Zimtsäurederivate und deren verwendung als integrin-antagonisten
ATE171066T1 (de) Pharmazeutische zubereitungen mit einem wirkstoff, der modifizierte amidingruppen enthält
RS50046B (sr) Farmaceutske kompozicije tizoksanida i nitazoksanida
FI823871L (fi) Foerfarande foer framstaellning av substituerade imidazolderivat
DK0823909T3 (da) Hidtil ukendte heterocykliske forbindelser
FI974444A (fi) N-hydroksiureayhdisteitä anti-inflammatorisina aineina
CA2169066A1 (en) Phenoxyphenyl Cyclopentenyl Hydroxyureas
FI950209A (fi) Farmakologisesti aktiiviset alfa-(tertiaarinen-amino-metyyli)-bentseenimetanolijohdannaiset
IT1254891B (it) Chinazoloni ad attivita' cardiovascolare

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee